Premium
SNOT ‐22 in a control population
Author(s) -
Erskine S.E.,
Hopkins C.,
Clark A.,
Anari S.,
Kumar N.,
Robertson A.,
Sunkaraneni S.,
Wilson J.A.,
Carrie S.,
Kara N.,
Ray J.,
Smith R.,
Philpott C.M.
Publication year - 2017
Publication title -
clinical otolaryngology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.914
H-Index - 68
eISSN - 1749-4486
pISSN - 1749-4478
DOI - 10.1111/coa.12667
Subject(s) - medicine , chronic rhinosinusitis , sinusitis , population , physical therapy , surgery , environmental health
Objectives To assess SNOT ‐22 and its subscales in a non‐rhinosinusitis UK ‐wide population. Design Self‐reported questionnaire. Setting Based from 30 ENT departments around the UK . Participants 250 Non‐rhinosinusitis adults – no self‐reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months. Main outcome measures SNOT ‐22, SF ‐36. Results The mean SNOT ‐22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5 and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains. Conclusions Our data demonstrate differences in SNOT ‐22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis.